News

Use the right tool for the job. Today, experts outline the best way to identify people most likely to develop common and devastating heart rhythm disorders. The advice is published in EP Europace,1 a journal of the European Society of...

As cities emerge from the pandemic lockdown, leading ambulatory cardiac monitoring provider InfoBionic and other industry experts are asking how the shutdowns can potentially affect heart health. One important aspect of learning more about...

Novadoz Pharmaceuticals, the U.S.-based sales and marketing affiliate for MSN Labs, located in Hyderabad India, recently received FDA approval for their generic versions of Oseltamivir Phosphate Capsules and Dofetilide capsules. The company...

Espero BioPharma, Inc., a pharmaceutical company focused on the development of therapeutics for unmet needs in thrombosis and cardiac rhythm control, expanded a collaborative partnering effort for its lead product candidate...

New analysis by Innovative Health details missed opportunities in single-use device reprocessing and provides roadmap for bolstering profitability in EP labs Innovative Health, Inc. released a new economic analysis that revealed today’s...

BioSig Technologies, Inc. and its majority-owned subsidiary, ViralClear Pharmaceuticals, Inc., announced that it has expanded its patient enrollment centers to include St. David’s South Austin Medical Center in Austin. The hospital is part of...

LindaCare is pleased to announce the appointment of Donald L. Deyo into the new roles of Executive Chairman of the LindaCare NV and President and CEO of the U.S. subsidiary, LindaCare Inc. Deyo has served as Chairman of the Board for the...

Siemens Healthineers (Formerly Known As Siemens Healthcare) and Geisinger Health System have established a 10-year Value Partnership to advance and support elements of Geisinger’s strategic priorities related to continually improving care for...

Stereotaxis, the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, announced it has reached a significant milestone of over 400 scientific publications now documenting the clinical benefits of...

The U.S. Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for Impella RP to include patients suffering from COVID-19 related right heart failure or decompensation, including pulmonary embolism...